End of an era: Sartorius boss steps down

Supervisory Board expresses great regret

03-Jul-2024 - The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be seeking another extension of his current contract when it expires in November 2025. The Supervisory Board has taken note ...

Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor

Manufacturing of instruments, consumables and reagents for cell and protein analysis

07-Jun-2024 - The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park. Sartorius has invested around 100 million US dollars in the state-of-the-art facility, consolidating existing sites and ...

Sartorius expects profitable growth in 2024

Double-digit annual sales revenue growth projected through to 2028

31-Jan-2024 - Sartorius expects a return to profitable growth in 2024 and a dynamic business development for the five-year period through to 2028. In 2023, soft demand, which lasted longer than expected post-pandemic, led to a temporary decline in sales revenue and earnings across the entire life science ...

Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

06-Jun-2023 - Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ ...

First quarter of Sartorius characterized by normalization of demand

Full-year outlook confirmed: uncertainties remain high due to the global political and economic situation

21-Apr-2023 - After the Covid-19-related business and inventory buildup by customers had triggered strong additional growth momentum in previous years, demand normalization at the life science group Sartorius continued throughout the first quarter of 2023, as expected, and led to a decline in sales revenue and ...

Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division

31-Mar-2023 - The Supervisory Board of Sartorius AG appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023. From June 16, 2023, Alexandra Gatzemeyer will succeed Gerry Mackay, Board Member and Head of the Lab Products & Services division, who will hand over duties in the ...

Sartorius with clear double-digit growth in fiscal 2022

Uncertainties due to the global political and economic situation remain high

27-Jan-2023 - Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability. Both divisions contributed to this development and, according to preliminary figures, recorded double-digit ...

Sartorius with continued growth in a challenging environment

Uncertainties due to the global political and economic situation currently remain high

19-Oct-2022 - Sartorius closed the first nine months of 2022 in both divisions with double-digit sales revenue and earnings growth and specified its outlook for the current fiscal year. “In the first nine months, Sartorius achieved significant growth in a challenging environment. Both divisions recorded ...

Sartorius records dynamic start to the new fiscal year

Global political and economic uncertainties substantially increased

22-Apr-2022 - Sartorius recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period. Based on its performance in the first three months, Sartorius confirms its outlook for fiscal 2022. “Sartorius had ...

Sartorius completes acquisition of Novasep’s chromatography division

Sales revenue forecast for 2022 updated due to acquisition

08-Feb-2022 - Sartorius announced that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasepchromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had already been agreed upon at the beginning of 2021. The ...